Patients with osteoporosis had a significantly higher risk of sudden sensorineural hearing loss (SSNHL) than those without osteoporosis, according to the first and largest Asian population-based study to demonstrate a relationship between the two conditions.
Those who suffer from OA may one day have a new and effective cell therapy, thanks to a team of Czech researchers who studied the effectiveness of using an OA patient’s own adipose (fat) cells in a unique transplant therapy aimed at reducing the symptoms of this prevalent and difficult to treat c
Between 1999 and 2013 opiate-related deaths nearly quadrupled, with the death rate rising from 1.4 to 5.1 deaths per 100,000. These alarming statistics have lead to greater regulation and oversight to opiate use.
Is it the making of a bubble, or the popping of it? Now we know.
The chikungunya epidemic has grown significantly in the Western hemisphere with an additional 3,000 cases worldwide during the past week.
In March 2014 the FDA approved apremilast (Otezla) for use in psoriatic arthritis based on three large"Palace" trials involving 1493 psoriatic arthritis patients. This ACR Hotline reviews the drugs use, efficacy, and toxicity.
Hemophagocytic lymphohistiocytosis(HLH) is a rare complication of many disorders. In children, systemic JIA is by far the most common cause of HLH.
The generic drug manufactuer Actavis joins Teva and Mylan with their lauch of celecoxib (Celebrex)in 50 mg, 100 mg, 200 mg and 400 mg capsules. In 2013 celecoxib was the 21st leading prescribed drug in the U.S. with $2.4 billion in sales as of mid 2014.
Gout's often told tale of a nocturnal rapid onset and dramatic pain provoked by a bed sheet, is studied in detail by Choi and the Boston online gout study. This report shows that more than half the attacks occur late night and are unrelated to alcohol or purine intake.
Older estimates suggested it would cost $1 billion to develop a new drug. ThisNY Times article discusses newer estimates claiming it cost 2.6 billion to bring a new drug to market.
Congress investigates why the price of more than 1,200 generic medications increased an average 448% betweeen 2013-2014.http://buff.ly/1v56VUt
WASHINGTON - Pregnant women are about to get easier-to-understand information on how safe their medicine is for baby.
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
